108606009: Salmeterol xinafoate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Receptor agonist\Adrenergic receptor agonist\Substance with beta adrenergic receptor agonist mechanism of action (substance)\Substance with beta-2 adrenergic receptor agonist mechanism of action (substance)\Salmeterol xinafoate

\Drug or medicament (substance)\Autonomic agent (substance)\Sympathomimetic agent (substance)\Adrenergic receptor agonist\Substance with beta adrenergic receptor agonist mechanism of action (substance)\Substance with beta-2 adrenergic receptor agonist mechanism of action (substance)\Salmeterol xinafoate
\Drug or medicament (substance)\Respiratory system agent (substance)\Bronchodilator\Substance with beta-2 adrenergic receptor agonist mechanism of action (substance)\Salmeterol xinafoate

\Substance categorised by structure\Chemical\Chemical categorized by structure\Organic compound\Organic cyclic compound\Substance with phenol structure\Salmeterol xinafoate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Salmeterol xinafoate	Is a	Product containing salmeterol (medicinal product)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol xinafoate	Is a	Salmeterol (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol xinafoate	Has disposition	Beta adrenergic receptor agonist (disposition)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol xinafoate	Has disposition	Beta-2 adrenergic receptor agonist	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol xinafoate	Is modification of (attribute)	Salmeterol (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol xinafoate	Is a	Substance with beta-2 adrenergic receptor agonist mechanism of action (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol xinafoate	Is a	Substance with phenol structure	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Salmeterol xinafoate 21mcg/spray aerosol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Salmeterol xinafoate	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol xinafoate 50mcg powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Salmeterol xinafoate	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol xinafoate 38.06mcg inhalant	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Salmeterol xinafoate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone- and salmeterol-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Salmeterol xinafoate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate + salmeterol xinafoate 250mcg/50mcg powder for oral inhalation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Salmeterol xinafoate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate + salmeterol xinafoate 500mcg/50mcg powder for oral inhalation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Salmeterol xinafoate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate + salmeterol xinafoate 100mcg/50mcg powder for oral inhalation (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Salmeterol xinafoate	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Salmeterol xinafoate	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 25micrograms/250micrograms CFC-free inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Salmeterol xinafoate	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 25micrograms/50micrograms CFC-free inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Salmeterol xinafoate	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 50micrograms/500micrograms breath-actuated dry powder inhaler (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Salmeterol xinafoate	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 25micrograms/125micrograms CFC-free inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Salmeterol xinafoate	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 50micrograms/250micrograms breath-actuated dry powder inhaler (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Salmeterol xinafoate	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation	Has precise active ingredient	True	Salmeterol xinafoate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation	Has precise active ingredient	True	Salmeterol xinafoate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug)	Has precise active ingredient	False	Salmeterol xinafoate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation	Has precise active ingredient	True	Salmeterol xinafoate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation	Has precise active ingredient	True	Salmeterol xinafoate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation	Has precise active ingredient	True	Salmeterol xinafoate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug)	Has precise active ingredient	True	Salmeterol xinafoate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation	Has precise active ingredient	True	Salmeterol xinafoate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely salmeterol (as salmeterol xinafoate) 21 microgram/1 actuation conventional release solution for inhalation (clinical drug)	Has precise active ingredient	True	Salmeterol xinafoate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug)	Has precise active ingredient	True	Salmeterol xinafoate	Inferred relationship	Existential restriction modifier (core metadata concept)	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
173140019	Salmeterol xinafoate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
602650010	Salmeterol xinafoate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
173140019	Salmeterol xinafoate	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
173140019	Salmeterol xinafoate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
602650010	Salmeterol xinafoate (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
602650010	Salmeterol xinafoate (substance)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
602650010	Salmeterol xinafoate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
28121000188110	salmétérol xinafoate	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
839291000172113	xinafoate de salmétérol	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
28121000188110	salmétérol xinafoate	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
839291000172113	xinafoate de salmétérol	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module